
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company opera... Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. Its lead projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services. 詳細を表示
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.042441 | -4.50378366218 | 0.942341 | 1.08 | 0.8009 | 34842 | 0.93138098 | CS |
4 | -0.3301 | -26.837398374 | 1.23 | 1.8 | 0.8009 | 129488 | 1.43602775 | CS |
12 | 0.1666 | 22.7192145098 | 0.7333 | 7.4899 | 0.672 | 2656932 | 2.61758105 | CS |
26 | -2.1801 | -70.7824675325 | 3.08 | 7.4899 | 0.46 | 1198228 | 2.59065607 | CS |
52 | -5.6101 | -86.1766513057 | 6.51 | 11.95 | 0.46 | 827602 | 3.90726173 | CS |
156 | -13.1001 | -93.5721428571 | 14 | 17.8 | 0.46 | 466960 | 5.84070681 | CS |
260 | -37.1001 | -97.6318421053 | 38 | 142.3 | 0.46 | 600246 | 17.53047504 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約